Novel insights into clear cell renal cell carcinoma prognosis by comprehensive characterization of aberrant alternative splicing signature: a study based on large-scale sequencing data

Clear cell renal cell carcinoma (ccRCC) is the most common type with poor prognosis in kidney tumor. Growing evidence has indicated that aberrant alternative splicing (AS) events are efficacious signatures for tumor prognosis prediction and therapeutic targets. However, the detailed roles of AS even...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Dong, Zhang, Wenjie, Sun, Rui, Huang, Zhongxian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806224/
https://www.ncbi.nlm.nih.gov/pubmed/33783315
http://dx.doi.org/10.1080/21655979.2021.1906096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806224/
https://www.ncbi.nlm.nih.gov/pubmed/33783315
http://dx.doi.org/10.1080/21655979.2021.1906096

Ejemplares similares